Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients

Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling

(2015) Bingqing Huang et al.   Oncotarget

Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus-Infected Carriers: A Prospective Study in Taiwan

(2014) C.-L. Chen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

(2014) Krasimira Aleksandrova et al.   HEPATOLOGY

P574 HIGH SENSITIVITY C-REACTIVE PROTEIN IS AN INDEPENDENT PREDICTOR FOR RECURRENCE AND SURVIVAL AFTER CURATIVE TREATMENT AMONG PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA IN EARLY STAGE

(2014) N. Fujiwara et al.   JOURNAL OF HEPATOLOGY

Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: A systematic review and meta-analysis

(2014) Zhen-Jie Wu et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adiponectin, cardiovascular disease, and mortality: Parsing the dual prognostic implications of a complex adipokine

(2014) Jorge R. Kizer   METABOLISM-CLINICAL AND EXPERIMENTAL

The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

(2013) Kathleen N. Ly et al.   ANNALS OF INTERNAL MEDICINE

Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology

(2013) P. Loria et al.   ATHEROSCLEROSIS

Plasma Levels of Adiponectin and Primary Liver Cancer Risk in Middle-Aged Japanese Adults with Hepatitis Virus Infection: A Nested Case-Control Study

(2013) T. Michikawa et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling

(2013) Guobin He et al.   CELL

Serum interleukin-6 associated with hepatocellular carcinoma risk: A nested case-control study

(2013) Waka Ohishi et al.   INTERNATIONAL JOURNAL OF CANCER

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

(2013) Miki Okada-Iwabu et al.   NATURE

Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma

(2012) Jeong Won Jang et al.   CYTOKINE

Adiponectin and All-Cause Mortality in Elderly People With Type 2 Diabetes

(2012) J. R. Singer et al.   DIABETES CARE

Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma

(2012) Wolfgang Sieghart et al.   HEPATOLOGY

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

(2012) David van der Poorten et al.   HEPATOLOGY

Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

(2012) M.-H. Lee et al.   JOURNAL OF INFECTIOUS DISEASES

The promoting effect of adiponectin in hepatocellular carcinoma

(2012) Ming-Jenn Chen et al.   JOURNAL OF SURGICAL ONCOLOGY

Inflammation- and stress-related signaling pathways in hepatocarcinogenesis

(2012) Hayato Nakagawa   WORLD JOURNAL OF GASTROENTEROLOGY

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

(2011) S. I. Grivennikov et al.   ANNALS OF THE RHEUMATIC DISEASES

Hepatitis C and non-Hodgkin lymphoma: The clinical perspective

(2011) Sidonie K. Hartridge-Lambert et al.   HEPATOLOGY

Obesity, inflammation, and liver cancer

(2011) Beicheng Sun et al.   JOURNAL OF HEPATOLOGY

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

IL-6 induces hepatic inflammation and collagen synthesis in vivo

(2010) I. CHOI et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Significance of serum adiponectin levels in patients with chronic liver disease

(2010) Maria Luisa Balmer et al.   CLINICAL SCIENCE

Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients

(2010) Toru Arano et al.   INTERNATIONAL JOURNAL OF CANCER

Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer

(2010) Catherine Duggan et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammation and Liver Cancer

(2009) C. Berasain et al.   Annals of the New York Academy of Sciences

Adipokines in liver diseases

(2009) Fabio Marra et al.   HEPATOLOGY

Adiponectin as a therapeutic target of non-alcoholic steatohepatitis

(2009)   HEPATOLOGY RESEARCH

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences

(2009) Hayato Nakagawa et al.   INTERNATIONAL JOURNAL OF CANCER

Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors

(2008) Anne M. Guiltinan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Adiponectin binds C1q and activates the classical pathway of complement

(2008) Philip W. Peake et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients

(2008) Takamasa Ohki et al.   Clinical Gastroenterology and Hepatology

Adiponectin and noncardiovascular death: a nested case-control study

(2008) Masatoshi Matsumoto et al.   METABOLISM-CLINICAL AND EXPERIMENTAL